F · Healthcare

Esperion Therapeutics Inc (0ET)

Drug Manufacturers - Specialty & Generic

Esperion Therapeutics Inc (0ET) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 0ET

P/E ratio

18.00

Esperion Therapeutics Inc (0ET) — FAQ

What is 0ET's P/E ratio?

The price-to-earnings (P/E) ratio for Esperion Therapeutics Inc (0ET) is 18.00 (data as of 2026-05-24).

Does Esperion Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Esperion Therapeutics Inc (0ET). Check the MyAverix Finance app for the latest dividend data.

What sector is Esperion Therapeutics Inc in?

Esperion Therapeutics Inc (0ET) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 0ET listed on?

0ET is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)